-

Bayer Consumer Health Welcomes Bayer 04 Leverkusen to Kick Off Historic Trophy Tour in the U.S. After Undefeated Bundesliga Season

The German professional football club, owned by Bayer, commemorates notable 2024 achievements by celebrating with Bayer employees and fans in the U.S.

WHIPPANY, N.J.--(BUSINESS WIRE)--After 120 years, Bayer 04 Leverkusen won its first Bundesliga earlier this year and now, the champions are taking the celebration on the road this month as the club embarks on its first-ever trophy tour in the U.S. Each year, the Bundesliga, Germany's top professional soccer league, awards the Meisterschale trophy to the winners of the season.

The tour will be led by Fernando Carro, CEO of Bayer 04 Leverkusen, along with team ambassador, former defender and 2006 World Cup semifinalist with Germany, Jens Nowotny. The pair, joined by team mascot Brian the Lion, will kick off the tour at Bayer Headquarters in Whippany, NJ, before heading to New York, NY to share with fans and partners the trophies from its historic ’23-’24 season, including Bundesliga, DFB Pokal and Supercup wins.

“It’s an honor to welcome and host Bayer 04 Leverkusen as the first stop of their trophy tour in the Americas,” said Dave Tomasi, President of Bayer North America. “The team’s accomplishments this past year have been truly inspiring, and their dedication and determination on the field truly match Bayer’s commitment to creating a better world where health and nutrition empower all. Here's to their journey of continued success and the shared values that make us all champions!"

Leverkusen is only the fifth German club to ever win the domestic double, becoming the first in Bundesliga history to finish the league championship undefeated. The team won 51 consecutive games during the season, the longest streak in the modern era. The wins continued up through the Europa League final in late May and the team went on to win the Supercup on August 18, winning on penalties after a late equalizer against Stuttgart.

“These trophies were a result of our incredible performance on the field this past year, but it was made possible from a strong foundation of people and teamwork that included everyone at and around the club and the Bayer parent company who support us,” said Carro. “For that reason, we bring these trophies overseas to show how they belong to all our Bayer colleagues and those in the global Bayer 04 family who waited so many years to win the league.”

This week’s activities in the New York area will include the trophy celebration with Bayer North America staff, Champions’ night hosted by Bayer Consumer Health, a media session and visit to the Bundesliga International Office in Union Square and a public viewing of the trophies for fans at a Matchday 3 watch party on Saturday, September 14. The event will take place at Radegast Biergarten in Brooklyn, with doors opening at 9 am to watch Bayer 04 Leverkusen take on TSG Hoffenheim at 9:30 am. Later that afternoon, the trophies will be displayed at Saturdays Football store on Broome Street in Lower Manhattan, where Leverkusen gear will be available for purchase.

To learn about Bayer 04 Leverkusen and see a schedule of upcoming matches, visit www.bayer04.de/en-us

For more information on Bayer, visit www.bayer.com

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros.

Bayer U.S. Social Media Channels: Facebook / X / Instagram

Bayer, the Bayer Cross is a trademark of Bayer.

Contacts

Danielle K. Goonan
Senior Director, Strategic Communications, Brand PR, Social and Influencer
danielle.goonan@bayer.com

Bayer Logo
Bayer Logo

Bayer


Release Summary
Bayer Consumer Health Welcomes Bayer 04 Leverkusen to Kick Off Historic Trophy Tour in the U.S. After Undefeated Bundesliga Season
Release Versions

Contacts

Danielle K. Goonan
Senior Director, Strategic Communications, Brand PR, Social and Influencer
danielle.goonan@bayer.com

More News From Bayer

Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Robigo, a biotechnology company engineering no-compromise biological solutions for crop protection, today announced a Series A funding led by Leaps by Bayer with participation from Illumina Ventures, SVG Thrive, Congruent Ventures, and Endeavor8. The round will accelerate the commercial launch of engineered microbial biopesticides combatting fungal diseases in soybeans and specialty crops in the United States, making these biologicals economically viable witho...

Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer today announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline and end-stage kidney disease in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D), following the agency’s Priority Review of the supplemental New Drug Application (...

Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road

WHIPPANY, N.J.--(BUSINESS WIRE)--Amid growing concerns over misinformation around health and science, Bayer launched a nationwide tour of its Science Delivers mobile interactive experience. The mobile display hits the road at a critical moment: a Harris Poll survey of 2,023 US adults, commissioned by Bayer – Science Under Siege: The Battle Between Viral Misinformation and Shared Belief in the Value of Science (March 2026) – found that 82% worry about their own and their families' wellbeing due...
Back to Newsroom